Combination therapy for the management of hypertension: A review of the evidence

This publication has 56 references indexed in Scilit:

• The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg
  International Journal Of Clinical Practice, 2009
• Results of a comparative, phase III, 12-week, multicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed-dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stage II hypertension
  Clinical Therapeutics, 2007
• Physician Awareness of Drug Cost: A Systematic Review
  PLOS Medicine, 2007
• Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004
  Hypertension, 2007
• Thiazide Diuretics, Potassium, and the Development of Diabetes
  Hypertension, 2006
• A Noninferiority Comparison of Valsartan/Hydrochlorothiazide Combination Versus Amlodipine in Black Hypertensives
  Hypertension, 2005
• Hydrochlorothiazide Versus Chlorthalidone
  Hypertension, 2004
• Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
  Hypertension, 2003
• Rationale for Fixed-Dose Combinations in the Treatment of Hypertension
  Drugs, 2002
• Is there a rationale for combining angiotensinconverting enzyme inhibitors and calcium antagonists in cardiovascular disease?
  American Heart Journal, 1997